The data shows the net ingredient cost (NIC) of human analogue insulins in England from 2005 to 2017. The NIC of human analogue insulins has increased since 2005/6. In 2016/17, the NIC was 303.6 million GBP.
2005/6 | 151.2 |
2006/7 | 185.3 |
2007/8 | 212.5 |
2008/9 | 238.6 |
2009/10 | 255.2 |
2010/11 | 269 |
2011/12 | 279.1 |
2012/13 | 282.1 |
2013/14 | 289 |
2014/15 | 293.7 |
2015/16 | 299.6 |
2016/17 | 303.6 |